Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Astrazeneca Pharma India has informed that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services have informed the Company on the attached request for Loss of Share Certificate from the claimant.
The above information is a part of company’s filings submitted to BSE.